価格表

在庫・価格 : 2025年04月26日 20時36分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-VEGF, Human, Goat-Poly
データシート※最新のデータシートでない場合があります
AF-293-NA RSDアールアンドディー システムズ
R&D Systems, Inc.
100 μg ¥106,000
(未発注)
追加

在庫・価格 : 2025年04月26日 20時36分 現在

Anti-VEGF, Human, Goat-Poly

  • 商品コード:AF-293-NA
  • メーカー:RSD
  • 包装:100μg
  • 価格: ¥106,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Hartlapp I et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J. 2001 Oct;15(12):2215-24
Hartlapp I et al
2001/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
2 Rissanen TT et al. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am. J. Pathol. 2002 Apr;160(4):1393-403
Rissanen TT et al
2002/01/01
Species: Human, Rabbit, Application: IHC Paraffin-embedded, Sample type: Whole Tissue PubMed
3 Noble JP et al. Palmar erythema: cutaneous marker of neoplasms. Dermatology (Basel) 2002;204(3):209-13
Noble JP et al
2002/01/01
Species: Human, Application: IHC Unspecified, Sample type: Whole Tissue PubMed
4 Faderl S et al. Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL). Leukemia 2002 Jun;16(6):1045-52
Faderl S et al
2002/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
5 McElhinney B et al. Ovarian hyperstimulation syndrome and assisted reproductive technologies: why some and not others? Hum. Reprod. 2002 Jun;17(6):1548-53
McElhinney B et al
2002/01/01
Application: ELISA Development, Sample Type: Serum PubMed
6 Sen CK et al. Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J. Biol. Chem. 2002 Sep;277(36):33284-90
Sen CK et al
2002/01/01
Application: IHC, Sample Type: Whole Cells PubMed
7 Sawaji Y et al. Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro. Br. J. Cancer 2002 May;86(10):1597-603
Sawaji Y et al
2002/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
8 Kats R et al. Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis. Fertil. Steril. 2002 Jul;78(1):69-76
Kats R et al
2002/01/01
Application: Neutralization, Sample Type: Peritoneal Fluid PubMed
9 Cho ML et al. Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Arthritis Rheum. 2002 May;46(5):1202-9
Cho ML et al
2002/01/01
Application: ELISA Development, Sample Type: Cell Supernates PubMed
10 Argraves WS et al. VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels. Dev. Dyn. 2002 Nov;225(3):298-304
Argraves WS et al
2002/01/01
Application: IHC Fresh,Neutralization, Sample Type: Whole Tissue PubMed
11 Keane MP et al. Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute respiratory distress syndrome. J. Immunol. 2002 Dec;169(11):6515-21
Keane MP et al
2002/01/01
Species: Human, Application: ELISA Development, IHC Paraffin-embedded, Sample type: BALF, Whole Tissue PubMed
12 Masood R et al. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int. J. Cancer 2003 May;104(5):603-10
Masood R et al
2003/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
13 Rimsza L et al. Endothelial stimulation by small lymphocytic lymphoma correlates with secreted levels of basic fibroblastic growth factor. Br. J. Haematol. 2003 Mar;120(5):753-8
Rimsza L et al
2003/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
14 Giuliani N et al. Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis. Blood 2003 Jul;102(2):638-45
Giuliani N et al
2003/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
15 Krum JM et al. Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: roles for VEGF in brain repair. Exp. Neurol. 2003 Jun;181(2):241-57
Krum JM et al
2003/01/01
Application: Neutralization PubMed
16 De S et al. Molecular pathway for cancer metastasis to bone. J. Biol. Chem. 2003 Oct;278(40):39044-50
De S et al
2003/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
17 Kanda S et al. Fibroblast growth factor-2-mediated capillary morphogenesis of endothelial cells requires signals via Flt-1/vascular endothelial growth factor receptor-1: possible involvement of c-Akt. J. Biol. Chem. 2004 Feb;279(6):4007-16
Kanda S et al
2004/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
18 Kim HK et al. Platelet microparticles induce angiogenesis in vitro. Br. J. Haematol. 2004 Feb;124(3):376-84
Kim HK et al
2004/01/01
Application: Neutralization PubMed
19 Hashimoto T et al. Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery 2004 Feb;54(2):410-23; discussion 423-5
Hashimoto T et al
2004/01/01
Species: Human, Application: IHC Unspecified, Western Blot, Sample type: Whole Tissue, Homogenized Tissue PubMed
20 Wang T et al. Alterations in angiogenic growth factors and neuronal nitric oxide synthase expression in chronic cavernosal ischemia. Int. J. Impot. Res. 2004 Oct;16(5):403-11
Wang T et al
2004/01/01
Application: IHC Fresh/Frozen, Sample Type: Whole Tissue PubMed
21 Jensen L et al. Effect of high intensity training on capillarization and presence of angiogenic factors in human skeletal muscle. J. Physiol. (Lond.) 2004 Jun;557(Pt 2):571-82
Jensen L et al
2004/01/01
Application: IHC Fresh/Frozen, Sample Type: Whole Tissue PubMed
22 Yang SP et al. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease. Neurobiol. Aging 2004 Mar;25(3):283-90
Yang SP et al
2004/01/01
Species: Human, Application: IHC Frozen, Sample type: Whole Tissue PubMed
23 Ca単ete JD et al. Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis. Arthritis Rheum. 2004 May;50(5):1636-41
Ca単ete JD et al
2004/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
24 Wright JL et al. Cigarette smoke induces persisting increases of vasoactive mediators in pulmonary arteries. Am. J. Respir. Cell Mol. Biol. 2004 Nov;31(5):501-9
Wright JL et al
2004/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
25 Desruisseau S et al. Clinical relevance of amphiregulin and VEGF in primary breast cancers. Int. J. Cancer 2004 Sep;111(5):733-40
Desruisseau S et al
2004/01/01
Application: ELISA Development, Sample Type: Homogenized Tissue PubMed
26 Seo KH et al. Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. Cancer Res. 2004 Sep;64(18):6482-8
Seo KH et al
2004/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
27 Oshima Y et al. Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization. J. Cell. Physiol. 2004 Dec;201(3):393-400
Oshima Y et al
2004/01/01
Application: IHC Fresh/Frozen, Sample Type: Whole Tissue PubMed
28 Sipos B et al. Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am. J. Pathol. 2004 Oct;165(4):1187-97
Sipos B et al
2004/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
29 Kitahara T et al. Mesangial cells stimulate differentiation of endothelial cells to form capillary-like networks in a three-dimensional culture system. Nephrol. Dial. Transplant. 2005 Jan;20(1):42-9
Kitahara T et al
2005/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
30 Vijayan V et al. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath. J. Vasc. Surg. 2004 Nov;40(5):1011-9
Vijayan V et al
2004/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
31 Puxeddu I et al. Human peripheral blood eosinophils induce angiogenesis. Int. J. Biochem. Cell Biol. 2005 Mar;37(3):628-36
Puxeddu I et al
2005/01/01
Sample Type: Whole Tissue PubMed
32 Djavani M et al. The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virus. J. Virol. 2005 Feb;79(4):2461-73
Djavani M et al
2005/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
33 Soufla G et al. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. Cancer Lett. 2006 Apr;235(1):100-13
Soufla G et al
2006/01/01
Application: Western Blot, Sample Type: Whole Tissue PubMed
34 Tanaka K et al. Age-associated aortic stenosis in apolipoprotein E-deficient mice. J. Am. Coll. Cardiol. 2005 Jul;46(1):134-41
Tanaka K et al
2005/01/01
Application: IHC Fresh/Frozen, Sample Type: Whole Tissue PubMed
35 Nakamura E et al. Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein. Am. J. Pathol. 2006 Feb;168(2):574-84
Nakamura E et al
2006/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
36 Bates DO et al. The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term. Clin. Sci. 2006 May;110(5):575-85
Bates DO et al
2006/01/01
Application: ELISA Development, Sample Type: Homogenized Tissue PubMed
37 Psarras S et al. Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses. J. Allergy Clin. Immunol. 2006 Feb;117(2):291-7
Psarras S et al
2006/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
38 Klos KS et al. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. Cancer Res. 2006 Feb;66(4
Klos KS et al
2006/01/01
Application: ELISA Development PubMed
39 Moreno MJ et al. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells. Glia 2006 Jun;53(8):845-57
Moreno MJ et al
2006/01/01
Species: Human, Application: Neutralization, Sample type: Whole Cells PubMed
40 Sun L et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006 Apr;9(4):287-300
Sun L et al
2006/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
41 Lee A et al. Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling. Cancer Res. 2006 Apr;66(8):4378-84
Lee A et al
2006/01/01
Species: Human, Application: IHC Fresh, Sample type: Whole Cells PubMed
42 Adachi Y et al. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas. Int. J. Cancer 2006 Sep;119(6):1303-11
Adachi Y et al
2006/01/01
Species: Human, Application: Neutralization, Whole Cells PubMed
43 Lucerna M et al. Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment. Blood 2007 Jan;109(1):122-9
Lucerna M et al
2007/01/01
Application: IHC, Sample Type: Whole Tissue PubMed
44 Yamagata M et al. Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects. FASEB J. 2006 Oct;20(12):2058-67
Yamagata M et al
2006/01/01
Application: ELISA Development, Sample Type: Cell Supernates PubMed
45 Raman V et al. Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model. Cancer Res. 2006 Oct;66(20):9929-36
Raman V et al
2006/01/01
Species: Human, Application: IHC Frozen, Whole Tissue PubMed
46 Yang EV et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 2006 Nov;66(21):10357-64
Yang EV et al
2006/01/01
Species: Human, Application: Neutralization, Whole Cells PubMed
47 Ferrari G et al. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2006 Nov;103(46):17260-5
Ferrari G et al
2006/01/01
Species: Human, Application: Neutralization, Sample type: Cell Lysates PubMed
48 Hong KH et al. Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Clin. Exp. Immunol. 2007 Mar;147(3):573-9
Hong KH et al
2007/01/01
Application: ELISA Development, Sample Type: Cell Supernates PubMed
49 Keskitalo S et al. Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein. Circ. Res. 2007 May;100(10):1460-7
Keskitalo S et al
2007/01/01
Species: Human, Application: Immunoprecipitation, Sample type: Whole Cells PubMed
50 Oh HK et al. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2. Cancer Res. 2007 May;67(10):4851-9
Oh HK et al
2007/01/01
Species: Human, Application: IHC Paraffin-embedded, Neutralization, Sample type: Whole Tissue, Whole Cells PubMed
51 Krilleke D et al. Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. J. Biol. Chem. 2007 Sep;282(38):28045-56
Krilleke D et al
2007/01/01
Species: Mouse, Application: IHC Frozen, Sample type: Whole Tissue PubMed
52 Qiu Y et al. Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b. FASEB J. 2008 Apr;22(4):1104-12
Qiu Y et al
2008/01/01
Species: Mouse, Application: ELISA Development, Homogenized Tissue PubMed
53 Hasina R et al. Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications. Lab. Invest. 2008 Apr;88(4):342-53
Hasina R et al
2008/01/01
Species: Human, Application: Neutralization, Whole Cells PubMed
54 Varey AH et al. VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br. J. Cancer 2008 Apr;98(8):1366
Varey AH et al
2008/01/01
Species: recombinant VEGF variants, Application: ELISA Development, Buffer PubMed
55 Klettner A et al. Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways. Invest. Ophthalmol. Vis. Sci. 2008 Oct;49(10):4523-7
Klettner A et al
2008/01/01
Species: Porcine, Application: Western Blot, Cell Lysates PubMed
56 Fan F et al. Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells. Mol. Cancer Ther. 2008 Sep;7(9):3064-70
Fan F et al
2008/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
57 Burton JB et al. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res. 2008 Oct;68(19):7828-37
Burton JB et al
2008/01/01
Species: Human, Application: Western Blot, Cell Lysates PubMed
58 Ponticelli S et al. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J. Biol. Chem. 2008 Dec;283(49):34250-9
Ponticelli S et al
2008/01/01
Application: ELISA Development, Sample Type: Other: Tetrameric 4-23-5 Peptide PubMed
59 Okada M et al. Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J. Am. Coll. Cardiol. 2008 Dec;52(23):1869-80
Okada M et al
2008/01/01
Application: IHC Frozen,IHC Paraffin, Sample Type: Whole Tissue PubMed
60 Rennel ES et al. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. Br. J. Cancer 2009 Oct;101(7):1183-93
Rennel ES et al
2009/01/01
Application: Western Blot, Sample Type: Cell Lysates,Homogenized Tissue PubMed
61 Martorell L et al. The hypoxia-inducible factor 1/NOR-1 axis regulates the survival response of endothelial cells to hypoxia. Mol. Cell. Biol. 2009 Nov;29(21):5828-42
Martorell L et al
2009/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
62 Varet J et al. VEGF in the lung: a role for novel isoforms. Am. J. Physiol. Lung Cell Mol. Physiol. 2010 Jun;298(6):L768-74
Varet J et al
2010/01/01
Application: ELISA Development, Sample Type: BALF PubMed
63 Brave SR et al. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model. Angiogenesis 2010 Dec;13(4):337-47
Brave SR et al
2010/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
64 Luo JZ et al. Human BM stem cells initiate angiogenesis in human islets in vitro. Bone Marrow Transplant. 2011 Aug;46(8):1128-37
Luo JZ et al
2011/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
65 Fan F et al. Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration. Br. J. Cancer 2011 Apr;104(8):1270-7
Fan F et al
2011/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
66 Zhao X et al. Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis. J. Immunol. Methods 2012 Apr;378(1-2):72-80
Zhao X et al
2012/01/01
Application: ELISA Development, Sample Type: Serum PubMed
67 Rolfo A et al. Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia. PLoS ONE 2013;8(3):e59403
Rolfo A et al
2013/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
68 Castriconi R et al. Neuroblastoma-derived TGF-β1 modulates the chemokine receptor repertoire of human resting NK cells. J. Immunol. 2013 May;190(10):5321-8
Castriconi R et al
2013/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
69 Bates DO et al. Detection of VEGF-A(xxx)b isoforms in human tissues. PLoS ONE 2013;8(7):e68399
Bates DO et al
2013/01/01
Application: Immunoprecipitation,Western Blot, Sample Type: Cell Lysate PubMed
70 Ruffini F et al. Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness. Oncol. Rep. 2013 Dec;30(6):2887-96
Ruffini F et al
2013/01/01
Application: ELISA Development, Sample Type: Cell culture supernatant PubMed
71 Orecchia A et al. Endothelial cell adhesion to soluble vascular endothelial growth factor receptor-1 triggers a cell dynamic and angiogenic phenotype. FASEB J. 2014 Feb;28(2):692-704
Orecchia A et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
72 Wang J et al. Simple patterned nanofiber scaffolds and its enhanced performance in immunoassay. PLoS ONE 2013;8(12):e82888
Wang J et al
2013/01/01
Application: micro-immunoassay development, Sample Type: recombinant protein PubMed
73 Choi SH et al. MMP9 processing of HSPB1 regulates tumor progression. PLoS ONE 2014;9(1):e85509
Choi SH et al
2014/01/01
Application: Western Blot, Sample Type: cell supernates PubMed
74 Meng HW et al. Discovering aptamers by cell-SELEX against human soluble growth factors ectopically expressed on yeast cell surface. PLoS ONE 2014;9(3):e93052
Meng HW et al
2014/01/01
Application: Flow Cytometry, Sample Type: Whole Cells PubMed
75 Shvartsman D et al. Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling. Mol. Ther. 2014 Jul;22(7):1243-53
Shvartsman D et al
2014/01/01
Application: In vivo neutralization, Sample Type: In Vivo PubMed
76 Park SY et al. HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1α activation. Eur. J. Immunol. 2015 Apr;45(4):1216-27
Park SY et al
2015/01/01
Application: Immunofluorescence, Sample Type: Whole Tissue PubMed
77 Zheng L et al. PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently. Oncotarget 2016 Nov;7(47):77902-77915
Zheng L et al
2016/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
78 Xu WW et al. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression. Nat Commun 2017 Feb;8:14399
Xu WW et al
2017/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
79 Yang S et al. CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cells. Oncol Lett 2017 Feb;13(2):898-904
Yang S et al
2017/01/01
Application: ICC, Sample Type: Whole Cells PubMed
80 Ikari J et al. Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease. PLoS ONE 2017;12(9):e0184039
Ikari J et al
2017/01/01
Species: Human, Applications: ELISA Capture PubMed
81 Hettema W et al. A randomized, single-blind, Phase I trial (INVICTAN-1) assessing the bioequivalence and safety of BI 695502, a bevacizumab biosimilar candidate, in healthy subjects. Expert Opin Investig Drugs 2017 Aug;26(8):889-896
Hettema W et al
2017/01/01
Species: Human, Applications: ELISA detection PubMed
82 Donzelli S et al. Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages. Breast Cancer Res. 2018 Jun;20(1):59
Donzelli S et al
2018/01/01
Species: Human, Applications: WB PubMed
83 Pehrsson S et al. Rapid Production of Human VEGF-A following Intradermal Injection of Modified VEGF-A mRNA Demonstrated by Cutaneous Microdialysis in the Rabbit and Pig <i>In Vivo</i>. Biomed Res Int 2019;2019:3915851
Pehrsson S et al
2019/01/01
PubMed
84 Gao Y et al. Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma. Stem Cells 2016 Apr;34(4):1112-22
Gao Y et al
2016/01/01
PubMed
85 Jalili R et al. Streamlined circular proximity ligation assay provides high stringency and compatibility with low-affinity antibodies. Proc. Natl. Acad. Sci. U.S.A. 2018 01;115(5):E925-E933
Jalili R et al
2018/01/01
PubMed
86 Njau F et al. Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice. PLoS One 2020;15(1):e0218494
Njau F et al
2020/01/01
PubMed
87 Wu JH et al. Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy. EMBO Mol Med 2020 02;12(2):e10154
Wu JH et al
2020/01/01
Species: Mouse, Applications: Neutralization PubMed
88 Donzelli S et al. Paracrine Signaling from Breast Cancer Cells Causes Activation of ID4 Expression in Tumor-Associated Macrophages. Cells 2020 02;9(2)
Donzelli S et al
2020/01/01
Species: Human, Applications: Western Blot PubMed
89 Dong D et al. Hyperoxia sensitizes hypoxic HeLa cells to ionizing radiation by downregulating HIF&#x2011;1&#x3B1; and VEGF expression. Mol Med Rep 2021 01;23(1)
Dong D et al
2021/01/01
Species: Human, Applications: Western Blot PubMed
90 Carbone ML et al. Multiple Sclerosis Treatment and Melanoma Development. Int J Mol Sci 2020 Apr;21(8)
Carbone ML et al
2020/01/01
Species: Human, Applications: ELISA PubMed
  • No.: 1
  • 文献情報:
    Hartlapp I et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J. 2001 Oct;15(12):2215-24
    Hartlapp I et al
    2001/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Rissanen TT et al. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am. J. Pathol. 2002 Apr;160(4):1393-403
    Rissanen TT et al
    2002/01/01
  • 備考:
    Species: Human, Rabbit, Application: IHC Paraffin-embedded, Sample type: Whole Tissue
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Noble JP et al. Palmar erythema: cutaneous marker of neoplasms. Dermatology (Basel) 2002;204(3):209-13
    Noble JP et al
    2002/01/01
  • 備考:
    Species: Human, Application: IHC Unspecified, Sample type: Whole Tissue
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Faderl S et al. Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL). Leukemia 2002 Jun;16(6):1045-52
    Faderl S et al
    2002/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    McElhinney B et al. Ovarian hyperstimulation syndrome and assisted reproductive technologies: why some and not others? Hum. Reprod. 2002 Jun;17(6):1548-53
    McElhinney B et al
    2002/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Sen CK et al. Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J. Biol. Chem. 2002 Sep;277(36):33284-90
    Sen CK et al
    2002/01/01
  • 備考:
    Application: IHC, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Sawaji Y et al. Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro. Br. J. Cancer 2002 May;86(10):1597-603
    Sawaji Y et al
    2002/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Kats R et al. Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis. Fertil. Steril. 2002 Jul;78(1):69-76
    Kats R et al
    2002/01/01
  • 備考:
    Application: Neutralization, Sample Type: Peritoneal Fluid
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Cho ML et al. Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Arthritis Rheum. 2002 May;46(5):1202-9
    Cho ML et al
    2002/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Argraves WS et al. VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels. Dev. Dyn. 2002 Nov;225(3):298-304
    Argraves WS et al
    2002/01/01
  • 備考:
    Application: IHC Fresh,Neutralization, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Keane MP et al. Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute respiratory distress syndrome. J. Immunol. 2002 Dec;169(11):6515-21
    Keane MP et al
    2002/01/01
  • 備考:
    Species: Human, Application: ELISA Development, IHC Paraffin-embedded, Sample type: BALF, Whole Tissue
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Masood R et al. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int. J. Cancer 2003 May;104(5):603-10
    Masood R et al
    2003/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Rimsza L et al. Endothelial stimulation by small lymphocytic lymphoma correlates with secreted levels of basic fibroblastic growth factor. Br. J. Haematol. 2003 Mar;120(5):753-8
    Rimsza L et al
    2003/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Giuliani N et al. Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis. Blood 2003 Jul;102(2):638-45
    Giuliani N et al
    2003/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Krum JM et al. Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: roles for VEGF in brain repair. Exp. Neurol. 2003 Jun;181(2):241-57
    Krum JM et al
    2003/01/01
  • 備考:
    Application: Neutralization
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    De S et al. Molecular pathway for cancer metastasis to bone. J. Biol. Chem. 2003 Oct;278(40):39044-50
    De S et al
    2003/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Kanda S et al. Fibroblast growth factor-2-mediated capillary morphogenesis of endothelial cells requires signals via Flt-1/vascular endothelial growth factor receptor-1: possible involvement of c-Akt. J. Biol. Chem. 2004 Feb;279(6):4007-16
    Kanda S et al
    2004/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Kim HK et al. Platelet microparticles induce angiogenesis in vitro. Br. J. Haematol. 2004 Feb;124(3):376-84
    Kim HK et al
    2004/01/01
  • 備考:
    Application: Neutralization
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Hashimoto T et al. Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery 2004 Feb;54(2):410-23; discussion 423-5
    Hashimoto T et al
    2004/01/01
  • 備考:
    Species: Human, Application: IHC Unspecified, Western Blot, Sample type: Whole Tissue, Homogenized Tissue
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Wang T et al. Alterations in angiogenic growth factors and neuronal nitric oxide synthase expression in chronic cavernosal ischemia. Int. J. Impot. Res. 2004 Oct;16(5):403-11
    Wang T et al
    2004/01/01
  • 備考:
    Application: IHC Fresh/Frozen, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Jensen L et al. Effect of high intensity training on capillarization and presence of angiogenic factors in human skeletal muscle. J. Physiol. (Lond.) 2004 Jun;557(Pt 2):571-82
    Jensen L et al
    2004/01/01
  • 備考:
    Application: IHC Fresh/Frozen, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Yang SP et al. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer&#39;s disease. Neurobiol. Aging 2004 Mar;25(3):283-90
    Yang SP et al
    2004/01/01
  • 備考:
    Species: Human, Application: IHC Frozen, Sample type: Whole Tissue
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Ca単ete JD et al. Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis. Arthritis Rheum. 2004 May;50(5):1636-41
    Ca単ete JD et al
    2004/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Wright JL et al. Cigarette smoke induces persisting increases of vasoactive mediators in pulmonary arteries. Am. J. Respir. Cell Mol. Biol. 2004 Nov;31(5):501-9
    Wright JL et al
    2004/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Desruisseau S et al. Clinical relevance of amphiregulin and VEGF in primary breast cancers. Int. J. Cancer 2004 Sep;111(5):733-40
    Desruisseau S et al
    2004/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Seo KH et al. Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. Cancer Res. 2004 Sep;64(18):6482-8
    Seo KH et al
    2004/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Oshima Y et al. Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization. J. Cell. Physiol. 2004 Dec;201(3):393-400
    Oshima Y et al
    2004/01/01
  • 備考:
    Application: IHC Fresh/Frozen, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Sipos B et al. Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am. J. Pathol. 2004 Oct;165(4):1187-97
    Sipos B et al
    2004/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Kitahara T et al. Mesangial cells stimulate differentiation of endothelial cells to form capillary-like networks in a three-dimensional culture system. Nephrol. Dial. Transplant. 2005 Jan;20(1):42-9
    Kitahara T et al
    2005/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Vijayan V et al. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath. J. Vasc. Surg. 2004 Nov;40(5):1011-9
    Vijayan V et al
    2004/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Puxeddu I et al. Human peripheral blood eosinophils induce angiogenesis. Int. J. Biochem. Cell Biol. 2005 Mar;37(3):628-36
    Puxeddu I et al
    2005/01/01
  • 備考:
    Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Djavani M et al. The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virus. J. Virol. 2005 Feb;79(4):2461-73
    Djavani M et al
    2005/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Soufla G et al. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. Cancer Lett. 2006 Apr;235(1):100-13
    Soufla G et al
    2006/01/01
  • 備考:
    Application: Western Blot, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Tanaka K et al. Age-associated aortic stenosis in apolipoprotein E-deficient mice. J. Am. Coll. Cardiol. 2005 Jul;46(1):134-41
    Tanaka K et al
    2005/01/01
  • 備考:
    Application: IHC Fresh/Frozen, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Nakamura E et al. Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein. Am. J. Pathol. 2006 Feb;168(2):574-84
    Nakamura E et al
    2006/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Bates DO et al. The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term. Clin. Sci. 2006 May;110(5):575-85
    Bates DO et al
    2006/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Psarras S et al. Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses. J. Allergy Clin. Immunol. 2006 Feb;117(2):291-7
    Psarras S et al
    2006/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Klos KS et al. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. Cancer Res. 2006 Feb;66(4
    Klos KS et al
    2006/01/01
  • 備考:
    Application: ELISA Development
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Moreno MJ et al. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells. Glia 2006 Jun;53(8):845-57
    Moreno MJ et al
    2006/01/01
  • 備考:
    Species: Human, Application: Neutralization, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Sun L et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006 Apr;9(4):287-300
    Sun L et al
    2006/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Lee A et al. Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling. Cancer Res. 2006 Apr;66(8):4378-84
    Lee A et al
    2006/01/01
  • 備考:
    Species: Human, Application: IHC Fresh, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Adachi Y et al. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas. Int. J. Cancer 2006 Sep;119(6):1303-11
    Adachi Y et al
    2006/01/01
  • 備考:
    Species: Human, Application: Neutralization, Whole Cells
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Lucerna M et al. Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment. Blood 2007 Jan;109(1):122-9
    Lucerna M et al
    2007/01/01
  • 備考:
    Application: IHC, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Yamagata M et al. Bactericidal/permeability-increasing protein&#39;s signaling pathways and its retinal trophic and anti-angiogenic effects. FASEB J. 2006 Oct;20(12):2058-67
    Yamagata M et al
    2006/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Raman V et al. Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model. Cancer Res. 2006 Oct;66(20):9929-36
    Raman V et al
    2006/01/01
  • 備考:
    Species: Human, Application: IHC Frozen, Whole Tissue
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Yang EV et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 2006 Nov;66(21):10357-64
    Yang EV et al
    2006/01/01
  • 備考:
    Species: Human, Application: Neutralization, Whole Cells
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Ferrari G et al. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2006 Nov;103(46):17260-5
    Ferrari G et al
    2006/01/01
  • 備考:
    Species: Human, Application: Neutralization, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Hong KH et al. Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Clin. Exp. Immunol. 2007 Mar;147(3):573-9
    Hong KH et al
    2007/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Keskitalo S et al. Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein. Circ. Res. 2007 May;100(10):1460-7
    Keskitalo S et al
    2007/01/01
  • 備考:
    Species: Human, Application: Immunoprecipitation, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Oh HK et al. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2. Cancer Res. 2007 May;67(10):4851-9
    Oh HK et al
    2007/01/01
  • 備考:
    Species: Human, Application: IHC Paraffin-embedded, Neutralization, Sample type: Whole Tissue, Whole Cells
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Krilleke D et al. Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. J. Biol. Chem. 2007 Sep;282(38):28045-56
    Krilleke D et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: IHC Frozen, Sample type: Whole Tissue
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Qiu Y et al. Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b. FASEB J. 2008 Apr;22(4):1104-12
    Qiu Y et al
    2008/01/01
  • 備考:
    Species: Mouse, Application: ELISA Development, Homogenized Tissue
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Hasina R et al. Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications. Lab. Invest. 2008 Apr;88(4):342-53
    Hasina R et al
    2008/01/01
  • 備考:
    Species: Human, Application: Neutralization, Whole Cells
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Varey AH et al. VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br. J. Cancer 2008 Apr;98(8):1366
    Varey AH et al
    2008/01/01
  • 備考:
    Species: recombinant VEGF variants, Application: ELISA Development, Buffer
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Klettner A et al. Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways. Invest. Ophthalmol. Vis. Sci. 2008 Oct;49(10):4523-7
    Klettner A et al
    2008/01/01
  • 備考:
    Species: Porcine, Application: Western Blot, Cell Lysates
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Fan F et al. Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells. Mol. Cancer Ther. 2008 Sep;7(9):3064-70
    Fan F et al
    2008/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Burton JB et al. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res. 2008 Oct;68(19):7828-37
    Burton JB et al
    2008/01/01
  • 備考:
    Species: Human, Application: Western Blot, Cell Lysates
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Ponticelli S et al. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J. Biol. Chem. 2008 Dec;283(49):34250-9
    Ponticelli S et al
    2008/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Other: Tetrameric 4-23-5 Peptide
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Okada M et al. Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J. Am. Coll. Cardiol. 2008 Dec;52(23):1869-80
    Okada M et al
    2008/01/01
  • 備考:
    Application: IHC Frozen,IHC Paraffin, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Rennel ES et al. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. Br. J. Cancer 2009 Oct;101(7):1183-93
    Rennel ES et al
    2009/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates,Homogenized Tissue
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Martorell L et al. The hypoxia-inducible factor 1/NOR-1 axis regulates the survival response of endothelial cells to hypoxia. Mol. Cell. Biol. 2009 Nov;29(21):5828-42
    Martorell L et al
    2009/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Varet J et al. VEGF in the lung: a role for novel isoforms. Am. J. Physiol. Lung Cell Mol. Physiol. 2010 Jun;298(6):L768-74
    Varet J et al
    2010/01/01
  • 備考:
    Application: ELISA Development, Sample Type: BALF
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Brave SR et al. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model. Angiogenesis 2010 Dec;13(4):337-47
    Brave SR et al
    2010/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Luo JZ et al. Human BM stem cells initiate angiogenesis in human islets in vitro. Bone Marrow Transplant. 2011 Aug;46(8):1128-37
    Luo JZ et al
    2011/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Fan F et al. Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration. Br. J. Cancer 2011 Apr;104(8):1270-7
    Fan F et al
    2011/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Zhao X et al. Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis. J. Immunol. Methods 2012 Apr;378(1-2):72-80
    Zhao X et al
    2012/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Rolfo A et al. Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia. PLoS ONE 2013;8(3):e59403
    Rolfo A et al
    2013/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Castriconi R et al. Neuroblastoma-derived TGF-&#x3B2;1 modulates the chemokine receptor repertoire of human resting NK cells. J. Immunol. 2013 May;190(10):5321-8
    Castriconi R et al
    2013/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Bates DO et al. Detection of VEGF-A(xxx)b isoforms in human tissues. PLoS ONE 2013;8(7):e68399
    Bates DO et al
    2013/01/01
  • 備考:
    Application: Immunoprecipitation,Western Blot, Sample Type: Cell Lysate
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Ruffini F et al. Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness. Oncol. Rep. 2013 Dec;30(6):2887-96
    Ruffini F et al
    2013/01/01
  • 備考:
    Application: ELISA Development, Sample Type: Cell culture supernatant
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Orecchia A et al. Endothelial cell adhesion to soluble vascular endothelial growth factor receptor-1 triggers a cell dynamic and angiogenic phenotype. FASEB J. 2014 Feb;28(2):692-704
    Orecchia A et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Wang J et al. Simple patterned nanofiber scaffolds and its enhanced performance in immunoassay. PLoS ONE 2013;8(12):e82888
    Wang J et al
    2013/01/01
  • 備考:
    Application: micro-immunoassay development, Sample Type: recombinant protein
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Choi SH et al. MMP9 processing of HSPB1 regulates tumor progression. PLoS ONE 2014;9(1):e85509
    Choi SH et al
    2014/01/01
  • 備考:
    Application: Western Blot, Sample Type: cell supernates
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Meng HW et al. Discovering aptamers by cell-SELEX against human soluble growth factors ectopically expressed on yeast cell surface. PLoS ONE 2014;9(3):e93052
    Meng HW et al
    2014/01/01
  • 備考:
    Application: Flow Cytometry, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Shvartsman D et al. Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling. Mol. Ther. 2014 Jul;22(7):1243-53
    Shvartsman D et al
    2014/01/01
  • 備考:
    Application: In vivo neutralization, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Park SY et al. HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1&#x3B1; activation. Eur. J. Immunol. 2015 Apr;45(4):1216-27
    Park SY et al
    2015/01/01
  • 備考:
    Application: Immunofluorescence, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Zheng L et al. PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently. Oncotarget 2016 Nov;7(47):77902-77915
    Zheng L et al
    2016/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Xu WW et al. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression. Nat Commun 2017 Feb;8:14399
    Xu WW et al
    2017/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Yang S et al. CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cells. Oncol Lett 2017 Feb;13(2):898-904
    Yang S et al
    2017/01/01
  • 備考:
    Application: ICC, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Ikari J et al. Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease. PLoS ONE 2017;12(9):e0184039
    Ikari J et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ELISA Capture
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Hettema W et al. A randomized, single-blind, Phase I trial (INVICTAN-1) assessing the bioequivalence and safety of BI 695502, a bevacizumab biosimilar candidate, in healthy subjects. Expert Opin Investig Drugs 2017 Aug;26(8):889-896
    Hettema W et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ELISA detection
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Donzelli S et al. Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages. Breast Cancer Res. 2018 Jun;20(1):59
    Donzelli S et al
    2018/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Pehrsson S et al. Rapid Production of Human VEGF-A following Intradermal Injection of Modified VEGF-A mRNA Demonstrated by Cutaneous Microdialysis in the Rabbit and Pig <i>In Vivo</i>. Biomed Res Int 2019;2019:3915851
    Pehrsson S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Gao Y et al. Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma. Stem Cells 2016 Apr;34(4):1112-22
    Gao Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Jalili R et al. Streamlined circular proximity ligation assay provides high stringency and compatibility with low-affinity antibodies. Proc. Natl. Acad. Sci. U.S.A. 2018 01;115(5):E925-E933
    Jalili R et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    Njau F et al. Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice. PLoS One 2020;15(1):e0218494
    Njau F et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Wu JH et al. Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy. EMBO Mol Med 2020 02;12(2):e10154
    Wu JH et al
    2020/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Donzelli S et al. Paracrine Signaling from Breast Cancer Cells Causes Activation of ID4 Expression in Tumor-Associated Macrophages. Cells 2020 02;9(2)
    Donzelli S et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Dong D et al. Hyperoxia sensitizes hypoxic HeLa cells to ionizing radiation by downregulating HIF&#x2011;1&#x3B1; and VEGF expression. Mol Med Rep 2021 01;23(1)
    Dong D et al
    2021/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Carbone ML et al. Multiple Sclerosis Treatment and Melanoma Development. Int J Mol Sci 2020 Apr;21(8)
    Carbone ML et al
    2020/01/01
  • 備考:
    Species: Human, Applications: ELISA
  • 参照:
    PubMed